Fetal Heart Rate Monitoring Patterns in Women with Amniotic Fluid Proteomic Profiles Indicative of Inflammation

 

 Buy Article Permissions and Reprints

ABSTRACT

We hypothesized that abnormal fetal heart rate monitoring patterns (FHR-MPs) occur more often in pregnancies complicated by intra-amniotic inflammation. Therefore, our objective was to examine the relationships among FHR-MP abnormalities, intra-amniotic inflammation and/or infection, acute histological chorioamnionitis, and early-onset neonatal sepsis (EONS) in pregnancies complicated by preterm birth. Additionally, the ability of various FHR-MPs to predict EONS was investigated. FHR-MPs from 87 singleton premature neonates delivered within 48 hours from amniocentesis (gestational age, mean ± SD: 28.9 ± 3.3 weeks) were analyzed blindly using strict National Institute of Child Health and Human Development criteria. Strips were evaluated at three time points: at admission, at amniocentesis, and prior to delivery. Intra-amniotic inflammation was established based on a previously validated proteomic fingerprint (mass-restricted score). Diagnoses of histological chorioamnionitis and EONS were based on well-recognized pathological, clinical, and laboratory criteria. We determined that fetuses of women with severe intra-amniotic inflammation had a higher FHR baseline throughout the entire monitoring period and an increased frequency of a nonreactive FHR-MP at admission. Of all FHR-MPs, a nonreassuring test at admission had 32% sensitivity, 95% specificity, 73% positive predictive value, 77% negative predictive value, and 76% accuracy in predicting EONS. Although a nonreassuring FHR-MP at admission was significantly associated with EONS after correcting for gestational age (odds ratio, 5.6; 95% confidence interval, 1.2 to 26.2; p = 0.030), the majority of the neonates that developed EONS had an overall reassuring FHR-MP. Nonreassuring FHR-MPs at either amniocentesis or delivery had no association with EONS. We conclude that in cases complicated by preterm birth, a nonreassuring FHR-MP at the initial evaluation is a specific but not a sensitive predictor of EONS. An abnormal FHR-MP can thus raise the level of awareness that a fetus with EONS may be born, but it is not a useful clinical indicator of the need for antibiotic treatment of the neonate.

REFERENCES

• 1 Renou P, Newman W, Wood C. Autonomic control of FHR.  Am J Obstet Gynecol. 1969;  105 949-053
  CrossrefPubMedGoogle Scholar
• 2 Van Leeuwen P, Cysarz D, Lange S, Gronemeyer D. Increase in regularity of FHR variability with age.  Biomed Tech (Berl). 2006;  51 244-247
  PubMedGoogle Scholar
• 3 Salafia C M, Ghidini A, Sherer D M, Pezzullo J C. Abnormalities of the FHR in preterm deliveries are associated with acute intra-amniotic infection.  J Soc Gynecol Investig. 1998;  5 188-191
  CrossrefPubMedGoogle Scholar
• 4 Fleming A D, Salafia C M, Vintzileos A M, Rodis J F, Campbell W A, Bantham K F. The relationships among umbilical artery velocimetry, fetal biophysical profile, and placental inflammation in preterm premature rupture of the membranes.  Am J Obstet Gynecol. 1991;  164 38-41
  PubMedGoogle Scholar
• 5 Salafia C M, Mangam H E, Weigl C A, Foye G J, Silberman L. Abnormal FHR patterns and placental inflammation.  Am J Obstet Gynecol. 1989;  160 140-147
  PubMedGoogle Scholar
• 6 Buhimschi C S, Bhandari V, Hamar B D et al.. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis.  PLoS Med. 2007;  4 e18
  CrossrefPubMedGoogle Scholar
• 7 Buhimschi C S, Buhimschi I A, Abdel-Razeq S et al.. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate.  Pediatr Res. 2007;  61 318-324
  CrossrefPubMedGoogle Scholar
• 8 Buhimschi I A, Zambrano E, Pettker C M et al.. Using proteomic analysis of the human amniotic fluid to identify histological chorioamnionitis.  Obstet Gynecol. 2008;  111 403-412
  PubMedGoogle Scholar
• 9 Vintzileos A M, Campbell W A, Nochimson D J, Weinbaum P J. The use of the nonstress test in patients with premature rupture of the membranes.  Am J Obstet Gynecol. 1986;  155 149-153
  PubMedGoogle Scholar
• 10 Schiano M A, Hauth J C, Gilstrap III L C. Second-stage fetal tachycardia and neonatal infection.  Am J Obstet Gynecol. 1984;  148 779-781
  PubMedGoogle Scholar
• 11 Day D, Ugol J H, French J I, Haverkamp A, Wall R E, McGregor J A. Fetal monitoring in perinatal sepsis.  Am J Perinatol. 1992;  9 28-33
  PubMedGoogle Scholar
• 12 Salafia C M, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies.  Obstet Gynecol. 1989;  73 383-389
  PubMedGoogle Scholar
• 13 Lewis D F, Bergstedt S, Edwards M S et al.. Successful magnesium sulfate tocolysis: is “weaning” the drug necessary?.  Am J Obstet Gynecol. 1997;  177 742-745
  CrossrefPubMedGoogle Scholar
• 14 Romero R, Yoon B H, Mazor M et al.. A comparative study of the diagnosis performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of the membranes.  Am J Obstet Gynecol. 1993;  169 839-851
  CrossrefPubMedGoogle Scholar
• 15 Naef III R W, Allbert J R, Ross E L, Weber B M, Martin R W, Morrison J C. Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management.  Am J Obstet Gynecol. 1998;  178 126-130
  PubMedGoogle Scholar
• 16 ACOG Committee Opinion . number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns.  Obstet Gynecol. 2002;  100 1405-1412
  CrossrefPubMedGoogle Scholar
• 17 ACOB Committee on Practice Bulletins-Obstetrics, ACOG Practice Bulletin . number 80, April 2007. Premature rupture of membranes.  Obstet Gynecol. 2007;  109 1007-1019
  PubMedGoogle Scholar
• 18 Electronic FHR monitoring: research guidelines for interpretation. National Institute of Child Health and Human Development Research Planning Workshop.  Am J Obstet Gynecol. 1997;  177 1385-1390
  PubMedGoogle Scholar
• 19 Sameshima H, Ikenoue T, Ikeda T, Kamitomo M, Ibara S. Association of nonreassuring FHR patterns and subsequent cerebral palsy in pregnancies with intrauterine bacterial infection.  Am J Perinatol. 2005;  22 181-187
  Article in Thieme ConnectPubMedGoogle Scholar
• 20 Edwards R K, Clark P, Locksmith Gregory J, Duff P. Performance characteristics of putative tests for subclinical chorioamnionitis.  Infect Dis Obstet Gynecol. 2001;  9 209-214
  PubMedGoogle Scholar
• 21 Garry D, Figueroa R, Aguero-Rosenfeld M, Martinez E, Visintainer P, Tejani N. A comparison of rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity and preterm delivery.  Am J Obstet Gynecol. 1996;  175 1336-1341
  CrossrefPubMedGoogle Scholar
• 22 Buhimschi I A, Christner R, Buhimschi C S. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation.  BJOG. 2005;  112 173-181
  PubMedGoogle Scholar
• 23 Park J S, Romero R, Yoon B et al.. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis.  Am J Obstet Gynecol. 2001;  185 1156-1161
  CrossrefPubMedGoogle Scholar
• 24 Harirah H, Donia S, Hsu C. Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection.  Obstet Gynecol. 2002;  99 80-84
  CrossrefPubMedGoogle Scholar
• 25 Naeye R L. Disorders of the placenta and decidua. In: Naeye RL Disorder of the Placenta, Fetus and Neonate: Diagnosis and Clinical Significance. St. Louis; Mosby 1992: 118-247
  Google Scholar
• 26 Smulian J C, Bhandari V, Campbell W A, Rodis J F, Vintzileos A M. Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis.  J Matern Fetal Med. 1997;  6 254-259
  CrossrefPubMedGoogle Scholar
• 27 Rodwell R L, Leslie A L, Tudehope D I. Early diagnosis of neonatal sepsis using a hematologic scoring system.  J Pediatr. 1988;  112 761-767
  CrossrefPubMedGoogle Scholar
• 28 Hill J B, Alexander J M, Sharma S K, McIntire D D, Leveno K J. A comparison of the effects of epidural and meperidine analgesia during labor on FHR.  Obstet Gynecol. 2003;  102 333-337
  CrossrefPubMedGoogle Scholar
• 29 Rotmensch S, Lev S, Kovo M et al.. Effect of betamethasone administration on FHR tracing: a blinded longitudinal study.  Fetal Diagn Ther. 2005;  20 371-376
  CrossrefPubMedGoogle Scholar
• 30 Ferriero D M. Neonatal brain injury.  N Engl J Med. 2004;  351 1985-1995
  CrossrefPubMedGoogle Scholar
• 31 Redline R W. Placental pathology and cerebral palsy.  Clin Perinatol. 2006;  33 503-516
  CrossrefPubMedGoogle Scholar
• 32 ACOG Committee on Obstetric Practice . ACOG Committee Opinion No. 348, November 2006: Umbilical cord blood gas and acid-base analysis.  Obstet Gynecol. 2006;  108 1319-1322
  CrossrefPubMedGoogle Scholar
• 33 Roberts A B, Goldstein I, Romero R, Hobbins J C. Comparison of total fetal activity measurement with the biophysical profile in predicting intra-amniotic infection in preterm premature rupture of membranes.  Ultrasound Obstet Gynecol. 1991;  1 36-39
  PubMedGoogle Scholar
• 34 Carroll S G, Papaioannou S, Nicolaides K H. Assessment of fetal activity and amniotic fluid volume in the prediction of intrauterine infection in preterm prelabor amniorrhexis.  Am J Obstet Gynecol. 1995;  172 1427-1435
  CrossrefPubMedGoogle Scholar
• 35 Day D, Ugol J H, French J I, Haverkamp A, Wall R E, McGregor J A. Fetal monitoring in perinatal sepsis.  Am J Perinatol. 1992;  9 28-33
  PubMedGoogle Scholar
• 36 Mishra U K, Jacobs S E, Doyle L W, Garland S M. Newer approaches to the diagnosis of early onset neonatal sepsis.  Arch Dis Child Fetal Neonatal Ed. 2006;  91 F208-F212
  PubMedGoogle Scholar
• 37 Rotmensch S, Lev S, Kovo M et al.. Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study.  Fetal Diagn Ther. 2005;  20 371-376
  CrossrefPubMedGoogle Scholar

Dr. Catalin S Buhimschi

Director of Perinatal Research, Yale University, Department of Obstetrics, Gynecology and Reproductive Sciences

333 Cedar Street, LLCI 804, New Haven, CT 06520